bit.bio Launches ioTracker™ Cells to Revolutionize Live-Cell Imaging and Drug Discovery

bit.bio, a Dynamk Capital portfolio company, has introduced ioTracker™ Cells, a new range of human iPSC-derived cells designed for precise live-cell imaging and drug discovery applications. These cells offer consistent, high-quality fluorescence labeling, enabling researchers to track cell behavior with unprecedented clarity. By combining bit.bio’s opti-ox™ precision cell programming technology with advanced imaging capabilities, ioTracker™ Cells streamline research workflows and accelerate breakthroughs in biomedical science.